417 related articles for article (PubMed ID: 24047394)
1. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
Mimura S; Ando T; Ishiguro K; Maeda O; Watanabe O; Ujihara M; Hirayama Y; Morise K; Maeda K; Matsushita M; Funasaka K; Nakamura M; Miyahara R; Ozaki N; Goto H
Scand J Gastroenterol; 2013 Oct; 48(10):1152-9. PubMed ID: 24047394
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2.
Ning MM; Yang WJ; Guan WB; Gu YP; Feng Y; Leng Y
Acta Pharmacol Sin; 2020 Nov; 41(11):1446-1456. PubMed ID: 32398684
[TBL] [Abstract][Full Text] [Related]
3. The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis.
Ban H; Bamba S; Imaeda H; Inatomi O; Kobori A; Sasaki M; Tsujikawa T; Andoh A; Fujiyama Y
Oncol Rep; 2011 Jun; 25(6):1699-703. PubMed ID: 21431278
[TBL] [Abstract][Full Text] [Related]
4. Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis.
Qi KK; Wu J; Wan J; Men XM; Xu ZW
Peptides; 2014 Feb; 52():11-8. PubMed ID: 24274971
[TBL] [Abstract][Full Text] [Related]
5. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
[TBL] [Abstract][Full Text] [Related]
6. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis.
Carlsson AH; Yakymenko O; Olivier I; Håkansson F; Postma E; Keita AV; Söderholm JD
Scand J Gastroenterol; 2013 Oct; 48(10):1136-44. PubMed ID: 23971882
[TBL] [Abstract][Full Text] [Related]
7. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999
[TBL] [Abstract][Full Text] [Related]
8. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
10. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
11. Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice.
Zhou M; Wang Z; Chen J; Zhan Y; Wang T; Xia L; Wang S; Hua Z; Zhang J
Br J Nutr; 2014 May; 111(10):1822-9. PubMed ID: 24480400
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis.
Yazbeck R; Howarth GS; Butler RN; Geier MS; Abbott CA
J Cell Physiol; 2011 Dec; 226(12):3219-24. PubMed ID: 21351101
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice.
Amrouche-Mekkioui I; Djerdjouri B
Eur J Pharmacol; 2012 Sep; 691(1-3):209-17. PubMed ID: 22732651
[TBL] [Abstract][Full Text] [Related]
14. Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration.
El-Jamal N; Erdual E; Neunlist M; Koriche D; Dubuquoy C; Maggiotto F; Chevalier J; Berrebi D; Dubuquoy L; Boulanger E; Cortot A; Desreumaux P
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G274-85. PubMed ID: 24875097
[TBL] [Abstract][Full Text] [Related]
15. The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.
Sakanaka T; Inoue T; Yorifuji N; Iguchi M; Fujiwara K; Narabayashi K; Kakimoto K; Nouda S; Okada T; Kuramoto T; Ishida K; Abe Y; Takeuchi T; Umegaki E; Akiba Y; Kaunitz JD; Higuchi K
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1(Suppl 1):60-5. PubMed ID: 25827806
[TBL] [Abstract][Full Text] [Related]
16. [Effect of balsalazide on intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice].
Liu XC; Mei Q; Xu JM; Hu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):193-6. PubMed ID: 19296261
[TBL] [Abstract][Full Text] [Related]
17. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
Lu F; Fernandes SM; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
[TBL] [Abstract][Full Text] [Related]
18. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
[TBL] [Abstract][Full Text] [Related]
19. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice.
Mishra SK; Kang JH; Kim DK; Oh SH; Kim MK
J Ethnopharmacol; 2012 Sep; 143(2):524-32. PubMed ID: 22819687
[TBL] [Abstract][Full Text] [Related]
20. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.
Salaga M; Mokrowiecka A; Zielinska M; Malecka-Panas E; Kordek R; Kamysz E; Fichna J
J Pharmacol Exp Ther; 2017 Oct; 363(1):92-103. PubMed ID: 28724693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
